NEXGEL, INC. Research and Development Expense
NEXGEL, INC. (NXGL) reported Research and Development Expense of $20.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-17
- NEXGEL, INC. research and development expense for the quarter ending 2026-06-30 was $20.00K.
- NEXGEL, INC. research and development expense for the quarter ending 2025-12-31 was -$6.00K.
- NEXGEL, INC. research and development expense for the quarter ending 2025-09-30 was $7.00K.
- NEXGEL, INC. research and development expense for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- NEXGEL, INC. research and development expense for fiscal 2025 was $2.00K, a 97.44% decline from fiscal 2024.
- NEXGEL, INC. research and development expense for fiscal 2024 was $78.00K, a 24.27% decline from fiscal 2023.
- NEXGEL, INC. research and development expense for fiscal 2023 was $103.00K, a 71.93% decline from fiscal 2022.
- NEXGEL, INC. research and development expense for fiscal 2022 was $367.00K, a 1083.87% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $20.00K 10-Q · filed 2026-08-17 | $20.00K 10-Q · filed 2026-08-17 | ||
| 2025-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.00K derived: sum of 2 quarters · filed 2026-03-31 | $1.00K derived: sum of 3 quarters · filed 2026-08-17 | $2.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $7.00K 10-Q · filed 2025-11-12 | $7.00K derived: sum of 2 quarters · filed 2026-08-17 | $8.00K 10-Q · filed 2025-11-12 | $8.00K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $1.00K 10-Q · filed 2026-08-17 | $1.00K derived: sum of 3 quarters · filed 2026-08-17 | $1.00K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $1.00K 10-Q · filed 2026-05-14 | $1.00K derived: sum of 2 quarters · filed 2026-05-14 | $1.00K derived: sum of 3 quarters · filed 2026-05-14 | $77.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $76.00K derived: sum of 3 quarters · filed 2026-03-31 | $78.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $76.00K derived: sum of 2 quarters · filed 2025-11-12 | $78.00K 10-Q · filed 2025-11-12 | $91.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $76.00K 10-Q · filed 2025-08-12 | $78.00K 10-Q · filed 2025-08-12 | $91.00K derived: sum of 3 quarters · filed 2025-08-12 | $97.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $2.00K 10-Q · filed 2025-05-13 | $15.00K derived: sum of 2 quarters · filed 2025-05-13 | $21.00K derived: sum of 3 quarters · filed 2025-05-13 | $76.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $19.00K derived: sum of 2 quarters · filed 2025-03-27 | $74.00K derived: sum of 3 quarters · filed 2025-03-27 | $103.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $6.00K 10-Q · filed 2024-11-13 | $61.00K derived: sum of 2 quarters · filed 2024-11-13 | $90.00K 10-Q · filed 2024-11-13 | $129.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $55.00K 10-Q · filed 2024-08-19 | $84.00K 10-Q · filed 2024-08-19 | $123.00K derived: sum of 3 quarters · filed 2024-08-19 | $316.00K derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $29.00K 10-Q · filed 2024-05-13 | $68.00K derived: sum of 2 quarters · filed 2024-05-13 | $261.00K derived: sum of 3 quarters · filed 2024-05-13 | $372.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $232.00K derived: sum of 2 quarters · filed 2024-04-10 | $343.00K derived: sum of 3 quarters · filed 2024-04-10 | $367.00K 10-K · filed 2024-04-10 |
| 2022-09-30 | $193.00K 10-Q · filed 2023-11-13 | $304.00K derived: sum of 2 quarters · filed 2023-11-13 | $328.00K 10-Q · filed 2023-11-13 | $342.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $111.00K 10-Q · filed 2023-08-14 | $135.00K 10-Q · filed 2023-08-14 | $149.00K derived: sum of 3 quarters · filed 2023-08-14 | $149.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $24.00K 10-Q · filed 2023-05-15 | $38.00K derived: sum of 2 quarters · filed 2023-05-15 | $38.00K derived: sum of 3 quarters · filed 2023-05-15 | $48.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $14.00K derived: sum of 2 quarters · filed 2023-03-28 | $24.00K derived: sum of 3 quarters · filed 2023-03-28 | $31.00K 10-K · filed 2023-03-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $10.00K derived: sum of 2 quarters · filed 2022-11-08 | $17.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $10.00K 10-Q · filed 2022-08-10 | $17.00K 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | $7.00K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |